Chronic Lymphocytic Leukemia (CLL), the most prevalent adult leukemia in western countries, which is highly heterogeneous with a very variable clinical outcome. Emerging evidence indicates that the stromal tumor…
proteins and Beclin 1, can mediate crosstalk between autophagy and apoptosis Chronic Lymphocytic Leukaemia (CLL) is a mature B cell neoplasm; presently an incurable disease representing the most common form…
Chronic Lymphocytic Leukemia (CLL) is a B-cell danger with an exceptionally factor clinical course. While a few patients require treatment moderately before long determination, others may stay liberated from
realize in hospital of Paris. Their was no argument for secondary localisation of CLL. Cerebral aspergillosis is rarely seen. His diagnosis is multidisciplinar. The pathologist need to exchange with clinicians
limited information about the function of circulating neutrophils in the chronic lymphocytic leukemia (CLL). The aim of the present study was to study functional properties of circulating neutrophils in CLL ... CLL…
zinc (Zn) and nitric oxide (NO) level in patients with chronic lymphocytic leukemia (CLL). Methods: Cu and Zn concentrations in the serum of 25 patients CLL and 15 healthy individuals ... increase in the mean serum…
mAbs) directed against lymphoid cells have been developed and investigated in chronic lymphocytic leukemia (CLL). Two mAbs have been demonstrated to have the most important clinical value in patients with ... CLL –…
cell chronic lymphocytic leukemia (B-CLL) is a heterogeneous disease with a wide variability in patients' clinical course. Numerous prognostic markers were introduced to screen for patients likely to have…
Statement of the Problem: Chronic lymphocytic leukemia (CLL) is an incurable disease with a highly heterogeneous clinical course, largely driven by molecular diversity. Although mutations in genes such as TP53…
Introduction: Chronic Lymphocytic Leukaemia (CLL) is a clonal B-cell neoplasm of mature cells whose diagnosis is based on clinical manifestations, cell morphology and Immunophenotyping. It is generally accepted that…
This study was carried out on 41 newly diagnosed chronic lymphocytic leukemia (CLL) patients for investigation of the diagnostic value of CD49d and its correlation with disease outcome in CLL ... patients. CD49d…
Introduction: In CLL patients, immune escape mechanisms allow leukemia cells to proliferate and expand. Human leukocyte antigen G (HLA-G) is a further strategy adopted by CLL cells to evade ... adaptive immunity. It has…
identify histone acetylation status of a number of gene promoters in chronic lymphocytic leukemia (CLL) specimens, we performed a combination of chromatin immunoprecipitation (ChIP) and PCR array. ChIP ... acetylation…
have shown that expression of miRNAs associates with disease aggressiveness in chronic lymphocytic leukemia (CLL), which is a disease where (dys) regulation of BCR signaling plays a prominent pathogenic role ... Here we…
Tagl gene polymorphisms in Turkish patients with multiple myeloma (MM), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML) and we compared the clinical features of the cases with gene…
Chronic lymphocytic leukemia (CLL) cell is characterized by a progressive accumulation of long-lived CD5+ B lymphocytes in bone marrow/lymph nodes, whose survival requires exogenous activation signals such ... growth…
Chronic lymphocytic leukemia (CLL) is a mature B-cell neoplasm with characteristic immunophenotype. This report presents a rare case of CLL with co-expression of T-cell marker ... cell receptor β and γ genes. The cell…
little is known about the prognostic importance of coexpression of CD49d and CD38 in CLL patients. Aim: The study aimed to investigate coexpression of both CD38 and CD49d as prognostic ... survival markers in CLL…
Objectives:Diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) depends on specific immunophenotype of select antigens and their characteristic density. However, reports detailing how the…
cell chronic lymphocytic leukemia (B-CLL) is a heterogeneous disease with some patients having an indolent course never needs treatment, while others having rapidly progressive one requires intensive treatment ... cells…
cell chronic lymphocytic leukemia (B-CLL) is a heterogeneous disease with some patients having an indolent course never needs treatment, while others having rapidly progressive one requires intensive treatment ... cells…
Patients with chronic lymphocytic leukemia (CLL) have profound defects in function of T-cells developing an exhausted phenotype which is recognized by the expression of multiple immune checkpoint receptors such…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.